María del Val Bermejo Sanz-rekin lankidetzan egindako argitalpenak (5)

2021

  1. Desarrollo de una IVIVC basada en disolución dinámica en el aparato USP IV aplicada a diferentes formulaciones de Montelukast

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 241-242

  2. One and two-step in vitro-in vivo correlations based on usp iv dynamic dissolution applied to four sodium montelukast products

    Pharmaceutics, Vol. 13, Núm. 5

2019

  1. Investigation to explain bioequivalence failure in pravastatin immediate-release products

    Pharmaceutics, Vol. 11, Núm. 12

2017

  1. IVIVC approach based on carbamazepine bioequivalence studies combination

    Pharmazie, Vol. 72, Núm. 8, pp. 449-455

2015

  1. Investigating the Discriminatory Power of BCS-Biowaiver in Vitro Methodology to Detect Bioavailability Differences between Immediate Release Products Containing a Class i Drug

    Molecular Pharmaceutics, Vol. 12, Núm. 9, pp. 3167-3174